Published
For women navigating a scary and uncertain breast cancer diagnosis, MammaPrint and BluePrint genomic assays analyze 150 genes across all 10 Hallmarks of Cancer that drive risk of recurrence and tumor growth. By illuminating tumor biology with MammaPrint and Blueprint, you can identify the genomic profile driving risk of recurrence and tumor growth in patients with HR+/HER2- early stage breast cancer.
- Categoria
- Oncology
Commenta per primo questo video.
Prossimo
-
12:40
Implementing Bispecific Antibodies: The Blueprint for Community Oncology Excellence
-
19:48
18 The BioVitality Blueprint Chapter 6 Bladder Leakage & UTIs Shortens Your Life
-
08:54
PSY101 Introduction to Psychology GDB Due Date 03 May 2024 Nature VS Nuture Blueprint determines
-
13:42
Genomic landscape of metaplastic breast cancer in the AACR GENIE cohort
-
19:40
Vscan Air™ Product Tutorial | Caption AI™
-
05:23
Genomic Testing in Breast Cancer
-
05:51
Precision oncology in prostate cancer: tips for optimal genomic testing
-
15:13
The Blueprint to Profitability in 2024
-
09:27
Foundation Frontiers Comprehensive Genomic Profiling Education - Mini-Molecular Tumor Board
-
08:22
Blueprint for Better Care: Innovation with Purpose, Empowered Teams, and Global Reach
-
09:07
Cardiology for Beginners: Basics of Heart Sounds and Murmurs (with examples)
-
13:45
How to Become a Cardiologist | Cardiac Electrophysiologist
-
04:14
V 00592 Cardiology Fellowship Video Dr Vranian V5
-
05:17
Cardiology Fellowship at SIU Medicine
-
04:15
Cardiology Fellowship Program at Danbury Hospital
-
05:49
Practice Question: Cardiology #1, USMLE Step 1, COMLEX Level 1
-
04:07
Dr. Muhammed Raza on advice for Fellows interested in Interventional Cardiology
-
07:36
Congenital Heart Disease – Cardiology | Lecturio
-
05:18
Cardiology Fellowship at IU School of Medicine
-
04:36
What are different types of Cardiology Tests | SPS Hospitals
